4 min read
James K. Min, MD, FACC, FESC, MSCCT, Founder & CEO of Cleerly: December 21, 2023
As we reach the end of 2023 and yet another remarkable year at Cleerly, it’s a great opportunity to reflect on all we’ve accomplished and begin...
2 min read
Cleerly: November 3, 2023
Cleerly has had a busy few months – attending conferences, panel sessions, and winning awards as we all work together to achieve our mission of a...
3 min read
James K. Min, MD, FACC, FESC, MSCCT, Founder & CEO of Cleerly: April 15, 2022
New research proposes a four-stage system for measuring the progression of cardiovascular disease (CAD) based on atherosclerotic plaque - not...
3 min read
Cleerly: March 11, 2022
There's a little-known fact in cardiology: Most of the care that's provided doesn't prevent heart attacks.
1 min read
Cleerly: March 7, 2022
Cleerly CEO James Min, M.D., is a guest on the latest episode of the AWS Health Innovation Podcast hosted by Joe Shonkwiler, M.D.
3 min read
Cleerly: February 14, 2022
Findings from Cleerly's groundbreaking echo the recent American College of Cardiology guidelines on the use of CCTA for non-invasive heart disease...
2 min read
Cleerly: February 8, 2022
As Cleerly makes its way into the clinical workflow of health systems and providers across the US, we are learning valuable information about how to...
4 min read
James K. Min, MD, FACC, FESC, MSCCT, Founder & CEO of Cleerly: January 28, 2022
Historically, our diagnostic approaches to patients with suspected heart disease have been restricted to the evaluation of patients with symptoms...
